Pasireotide LAR in Severe Polycystic Liver Disease

NCT01670110 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mayo Clinic